Effect of resveratrol supplementation on hepatic steatosis and cardiovascular indices in overweight subjects with type 2 diabetes: a double-blind, randomized controlled trial

BACKGROUND: Patients with type 2 diabetes mellitus (T2DM) are prone to develop non-alcoholic fatty liver disease (NAFLD) and cardiovascular diseases (CVD). We aimed to investigate whether the resveratrol supplementation improves novel hepatic and cardiovascular indices in these patients. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali Sangouni, Abbas, Abdollahi, Shima, Mozaffari-Khosravi, Hassan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088077/
https://www.ncbi.nlm.nih.gov/pubmed/35538431
http://dx.doi.org/10.1186/s12872-022-02637-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088077/
https://www.ncbi.nlm.nih.gov/pubmed/35538431
http://dx.doi.org/10.1186/s12872-022-02637-2

Ejemplares similares